Stay updated on Obicetrapib + Ezetimibe Adjunct in HIS Therapy Clinical Trial
Sign up to get notified when there's something new on the Obicetrapib + Ezetimibe Adjunct in HIS Therapy Clinical Trial page.

Latest updates to the Obicetrapib + Ezetimibe Adjunct in HIS Therapy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe Record History shows updates to the ROSE2 trial across multiple versions, including recruitment and study status changes in 2022 and a 2024 update that adds/adjusts Study Status, Outcome Measures, and related sections, along with updates to Contacts/Locations and Study Design.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference13%

- Check47 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%

- Check61 days agoChange DetectedCore content updated to v3.0.2, indicating a new release. The 'Back to Top' navigation element was removed, a minor UI change.SummaryDifference0.8%

- Check68 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.8%

- Check75 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference11%

Stay in the know with updates to Obicetrapib + Ezetimibe Adjunct in HIS Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obicetrapib + Ezetimibe Adjunct in HIS Therapy Clinical Trial page.